Followers | 76 |
Posts | 3712 |
Boards Moderated | 0 |
Alias Born | 10/23/2010 |
Thursday, November 18, 2010 7:00:37 PM
Representing less than one-half of one percent of EOG's total North American production, this Marcellus Shale acreage in northeastern Pennsylvania includes five producing natural gas wells with 7 million cubic feet per day of gross production. Following the close of the divestiture, EOG retains approximately 170,000 net acres in the Marcellus Shale in northwestern Pennsylvania.
With this transaction and others that EOG has signed or anticipates signing by year-end 2010, EOG estimates that the total proceeds from these asset sales will be approximately $1.0 billion.
"The sale of this Marcellus acreage is a part of EOG's previously announced tactical plan to sell certain producing and non-producing natural gas assets in North America. These sales will add liquidity to partially fund EOG's liquids weighted capital expenditure program," said Mark G. Papa, Chairman and Chief Executive Officer.
EOG Resources, Inc. is one of the largest independent (non-integrated) oil and natural gas companies in the United States with proved reserves in the United States, Canada, Trinidad, the United Kingdom and China. EOG Resources, Inc. is listed on the New York Stock Exchange and is traded under the ticker symbol "EOG."
This is not an offer to buy or sell securities or any kind of investment advice. Oil investment carries very high risks so consult a licensed professional making any decisions. My track record is real time @TurnKeyOil
Recent NFX News
- Nuformix PLC Result of AGM • RNS Regulatory News • 03/19/2024 02:39:02 PM
- Nuformix announces subscription to raise GBP150,000 • Alliance News • 03/01/2024 10:31:01 AM
- Nuformix PLC Subscription to raise £150,000 • RNS Regulatory News • 03/01/2024 07:00:04 AM
- Nuformix PLC Posting of Annual Report and Notice of AGM • UK Regulatory • 01/15/2024 11:30:00 AM
- Nuformix narrows annual loss as develops drug assets • Alliance News • 01/03/2024 10:16:07 AM
- Nuformix PLC Results for the period ended 30 September 2023 • UK Regulatory • 01/03/2024 07:00:00 AM
- Nuformix PLC NXP001 Update • UK Regulatory • 12/18/2023 07:00:00 AM
- Nuformix gets patent in Japan for pulmonary fibrosis treatment NXP002 • Alliance News • 10/23/2023 11:38:39 AM
- Nuformix PLC Notice of Allowance of NXP002 Patent in Japan • UK Regulatory • 10/23/2023 06:04:00 AM
- Nuformix to receive milestone payments from Oxilio pact • Alliance News • 09/18/2023 09:20:54 AM
- Nuformix PLC NXP001 Update • UK Regulatory • 09/18/2023 06:00:00 AM
- Nuformix PLC Result of Annual General Meeting • UK Regulatory • 08/24/2023 12:22:00 PM
- Nuformix PLC Notice of AGM • UK Regulatory • 07/31/2023 01:00:00 PM
- Nuformix PLC Holding(s) in Company • UK Regulatory • 07/26/2023 01:55:00 PM
- Nuformix PLC Investor Online Q&A • RNS Non-Regulatory • 06/02/2023 06:00:00 AM
- Nuformix PLC Change of Auditor • UK Regulatory • 05/25/2023 06:00:00 AM
- Nuformix loss narrows; near-term goal to focus on NXP002 asset • Alliance News • 05/22/2023 11:45:14 AM
- Nuformix PLC Unaudited Interim Report • UK Regulatory • 05/22/2023 06:00:00 AM
- Nuformix says NXP002 shows anti-inflammatory effect • Alliance News • 05/18/2023 01:31:17 PM
- Nuformix PLC NXP002 Inflammation and Duration of Action Update • UK Regulatory • 05/18/2023 06:00:00 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM